Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,858,347
-
Share change
-
-1,207,798
-
Total reported value
-
$97,627,252
-
Price per share
-
$52.51
-
Number of holders
-
46
-
Value change
-
-$64,396,543
-
Number of buys
-
23
-
Number of sells
-
25
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2016
As of 31 Dec 2016,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,858,347 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, UBS Group AG, MORGAN STANLEY, RAYMOND JAMES & ASSOCIATES, MAYO INVESTMENT ADVISERS LLC, ROYAL BANK OF CANADA, and STUYVESANT CAPITAL MANAGEMENT.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.